CHRISTOPHER LAMOTTE

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant HARLINGEN, TX NPI 1275812349

General Payments — all program years on this page

$2,223.20

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 60
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $718.76 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $718.7619

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $778.0124
2022 $241.279
2023 $485.168
2024 $718.7619

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078202683 Janssen Pharmaceuticals, Inc $100.45 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087127916 Novartis Pharmaceuticals Corporation $24.92 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101208020 E.R. Squibb & Sons, L.L.C. $4.93 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101208026 E.R. Squibb & Sons, L.L.C. $125.00 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101208058 E.R. Squibb & Sons, L.L.C. $1.37 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101208060 E.R. Squibb & Sons, L.L.C. $3.18 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101208062 E.R. Squibb & Sons, L.L.C. $8.31 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101208074 E.R. Squibb & Sons, L.L.C. $34.94 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101208084 E.R. Squibb & Sons, L.L.C. $98.87 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101208086 E.R. Squibb & Sons, L.L.C. $36.94 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104300220 AstraZeneca Pharmaceuticals LP $18.84 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104330802 AstraZeneca Pharmaceuticals LP $13.46 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105781142 AstraZeneca Pharmaceuticals LP $21.04 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116751122 Endologix LLC $28.14 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117945481 Boehringer Ingelheim Pharmaceuticals, Inc. $33.91 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145798096 BIOTRONIK INC. $46.00 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145798100 BIOTRONIK INC. $27.72 09/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145798224 BIOTRONIK INC. $31.96 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145798242 BIOTRONIK INC. $58.78 06/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.